Zong Yang, Huang Rongrong, Bitar Mireille, Drakaki Alexandra, Zhang Liying, Lin Douglas I, Ye Huihui
Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, California; Now with Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin.
Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, California.
Mod Pathol. 2025 Apr;38(4):100702. doi: 10.1016/j.modpat.2024.100702. Epub 2024 Dec 25.
Embryonic-type neuroectodermal tumors (ENTs) arising from testicular germ cell tumors (GCTs) are a relatively common type of somatic transformation in GCTs with poor prognosis and limited therapeutic options, particularly when patients develop disease recurrence or metastasis. Knowledge of key events driving this transformation is limited to the paucity of comprehensive genomic data. We performed a retrospective database search in a Clinical Laboratory Improvement Amendments- and College of American Pathologists-certified laboratory for testicular GCT-derived ENTs that had previously undergone next-generation sequencing-based comprehensive genomic profiling during the course of clinical care. Clinicopathological and genomic data were centrally rereviewed. Here, we report the molecular features of 10 ENTs of testicular GCT origin. All tumors harbored gain of chromosome 12p, often with KRAS, CCND2, and KMD5A coamplification, supporting a germ cell origin. The tumors were microsatellite-stable and exhibited a low tumor mutational burden. Three tumors (30%) exhibited MYCN or MYC amplification with co-occurring inactivation of the p53 pathway via either TP53 mutations or MDM2 amplification in 2 tumors. Three additional tumors (30%) had activation of the PI3K pathway via PIK3CA and PIK3CG mutations or PIK3C2B amplification; 1 tumor with co-occurring CDK4 amplification. Gene rearrangements were detected in 3 tumors (30%), with novel BRD4::MAU2 and BCOR::CLIP2 fusions as well as an internal truncating ATRX rearrangement, respectively. In summary, ENTs arising from GCTs are molecularly heterogeneous; however, a large fraction of testicular ENTs could be stratified by 2 distinct sets of genetic alterations, including MYCN/MYC amplification with concurrent suppression of the p53 pathway, and activation of the PI3K pathway with co-occurring CDK4 amplification. Moreover, the novel gene fusions identified in a subset of testicular GCT-derived ENTs overlap with molecularly defined tumors of embryonic-type neuroectodermal features in the central nervous system, indicating the potential common driving events for tumorigenesis from different anatomical sites.
起源于睾丸生殖细胞肿瘤(GCT)的胚胎型神经外胚层肿瘤(ENT)是GCT中一种相对常见的体细胞转化类型,预后较差且治疗选择有限,尤其是当患者出现疾病复发或转移时。由于缺乏全面的基因组数据,对于驱动这种转化的关键事件的了解有限。我们在一个经临床实验室改进修正案和美国病理学家学会认证的实验室中进行了一项回顾性数据库搜索,以查找先前在临床护理过程中接受过基于二代测序的全面基因组分析的睾丸GCT来源的ENT。对临床病理和基因组数据进行了集中重新审查。在此,我们报告了10例睾丸GCT起源的ENT的分子特征。所有肿瘤均存在12号染色体短臂增益,常伴有KRAS、CCND2和KMD5A共扩增,支持生殖细胞起源。这些肿瘤微卫星稳定,肿瘤突变负荷低。3例肿瘤(30%)表现出MYCN或MYC扩增,其中2例肿瘤通过TP53突变或MDM2扩增同时发生p53通路失活。另外3例肿瘤(30%)通过PIK3CA和PIK3CG突变或PIK3C2B扩增激活PI3K通路;1例肿瘤同时发生CDK4扩增。在3例肿瘤(30%)中检测到基因重排分别为新型BRD4::MAU2和BCOR::CLIP2融合以及内部截断性ATRX重排。总之,GCT来源的ENT在分子水平上具有异质性;然而,大部分睾丸ENT可通过两组不同的基因改变进行分层,包括MYCN/MYC扩增同时伴有p53通路抑制,以及PI3K通路激活同时伴有CDK4扩增。此外,在一部分睾丸GCT来源的ENT中鉴定出的新型基因融合与中枢神经系统中分子定义的具有胚胎型神经外胚层特征的肿瘤重叠,表明不同解剖部位肿瘤发生的潜在共同驱动事件。